Bristol Myers moves to enforce transgenic mice award
US pharmaceuticals company Bristol Myers Squibb has asked a US court to enforce an AAA award it won against Switzerland’s Novartis over royalty payments due for the use of genetically modified laboratory mice.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.